TELA Bio
Pre-clinicalDevelops and markets soft tissue reconstruction products using natural tissue reinforcement technology.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $120M
About
Develops and markets soft tissue reconstruction products using natural tissue reinforcement technology.
Medical DevicesRegenerative Medicine
Funding History
4Total raised:$120M
IPO$60MOct 25, 2019
Series C$30MJun 15, 2017
Series B$20MJun 15, 2015
Series A$10MJun 15, 2013